Page last updated: 2024-08-22

metopimazine and Basal Ganglia Diseases

metopimazine has been researched along with Basal Ganglia Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galley, M; Heguy, J; Montastruc, JL; Plantavid, M; Seigneuric, C; Sorbette, F1
Angelo, HR; Hansen, M; Herrstedt, J; Kampmann, JP; Sigsgaard, T1

Trials

1 trial(s) available for metopimazine and Basal Ganglia Diseases

ArticleYear
Dose-finding study of oral metopimazine.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1997, Volume: 5, Issue:1

    Topics: Administration, Oral; Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Basal Ganglia Diseases; Blood Pressure; Dizziness; Dose-Response Relationship, Drug; Female; Forecasting; Headache; Humans; Hypotension, Orthostatic; Isonipecotic Acids; Male; Middle Aged; Sleep Stages; Xerostomia

1997

Other Studies

1 other study(ies) available for metopimazine and Basal Ganglia Diseases

ArticleYear
[Extrapyramidal syndrome. Possible role of metopimazine].
    Presse medicale (Paris, France : 1983), 1983, Apr-02, Volume: 12, Issue:15

    Topics: Basal Ganglia Diseases; Humans; Isonipecotic Acids; Male; Middle Aged

1983